Related Experiment Video
Updated: Sep 22, 2025

Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics
Published on: February 19, 2017
Immunomagnetic leukocyte differential in whole blood on an electronic microdevice
Ozgun Civelekoglu1, Tevhide Ozkaya-Ahmadov1, A K M Arifuzzman1
1School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, USA. sarioglu@gatech.edu.
Insights
This study introduces a portable microfluidic chip for leukocyte differential analysis, offering a low-cost, point-of-care alternative to bulky lab equipment. The novel magnetic CD33 expression assay achieves high accuracy, enabling accessible health monitoring.
Area of Science:
- Immunology
- Biomedical Engineering
- Microfluidics
Background:
- Leukocyte differential analysis is vital for diagnosing infections and assessing health risks.
- Current methods rely on bulky, expensive equipment operated by trained personnel.
- There is a need for portable, cost-effective diagnostic tools.
Purpose of the Study:
- To develop a portable microfluidic chip for rapid leukocyte differential analysis.
- To utilize magnetic analysis of CD33 expression for accurate cell identification.
- To enable point-of-care and at-home hematology testing.
Main Methods:
- Development of an integrated microfluidic chip for leukocyte processing.
- Magnetic analysis of CD33 expression on leukocytes for differential counting.
- Benchmarking the microfluidic chip against conventional hematology analyzers and flow cytometers.
Main Results:
- The microfluidic chip achieved an average difference of <5% compared to conventional methods for all leukocyte subtypes.
- Demonstrated high accuracy and reliability in leukocyte differential analysis.
- Validated the potential for decentralized hematology testing.
Conclusions:
- The developed microfluidic technology offers a portable and accurate solution for leukocyte differential analysis.
- This innovation can significantly reduce the cost and increase accessibility of hematology testing.
- The technology paves the way for point-of-care and at-home health monitoring.
Abstract:
Leukocytes are the frontline defense mechanism of the immune system. Their composition dynamically changes as a response to a foreign body, infection, inflammation, or other malignant behavior occurring within the body. Monitoring the composition of leukocytes, namely leukocyte differential, is a crucial assay periodically performed to diagnose an infection or to assess a person's vulnerability for a health anomaly. Currently, leukocyte differential analysis is performed using hematology analyzers or flow cytometers, both of which are bulky instruments that require trained and certified personnel for operation. In this work, we demonstrate a new technique to obtain leukocyte differentials in a highly portable and integrated microfluidic chip by magnetically analyzing the CD33 expression of leukocytes. When benchmarked against conventional laboratory instruments, our technology demonstrated <5% difference on average for all subtypes. Our results show that hematology testing could be performed beyond the centralized laboratories at a low cost and ultimately provide point-of-care and at-home testing opportunities.

